VCM
BMY icon

Voleon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Voleon Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$448K Buy
7,380
+734
+11% +$42.8K 0.01% 595
2025
Q4 		$358K Sell
6,646
-19,092
-74% -$918K 0.01% 642
2025
Q3 		$1.16M Buy
25,738
+10,064
+64% +$470K 0.03% 409
2025
Q2 		$726K Buy
+15,674
New +$769K 0.04% 276
2025
Q1 		– Sell
-37,313
Closed -$2.11M – 338
2024
Q4 		$2.11M Buy
+37,313
New +$2.08M 0.16% 135

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Voleon Capital Management's BMY Position: Q1 2026 in Review

Voleon Capital Management increased its Bristol-Myers Squibb (BMY) stake by 11% in Q1 2026, buying an estimated $42.8K and bringing the position to 7,380 shares worth $448K. The position accounts for 0.01% of the portfolio, ranked #595.

Voleon Capital Management first reported a position in BMY in Q4 2024 and has held it in 5 quarters since. The position peaked at $2.11M in Q4 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Voleon Capital Management held 7,380 shares of Bristol-Myers Squibb worth $448K as of Q1 2026.
  • Voleon Capital Management bought 734 Bristol-Myers Squibb shares in Q1 2026, an estimated $42.8K.
  • Bristol-Myers Squibb made up 0.01% of Voleon Capital Management's portfolio in Q1 2026, its #595 holding.
  • Voleon Capital Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 5 quarters since.
  • Voleon Capital Management's Bristol-Myers Squibb position peaked at $2.11M in Q4 2024.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.